Corrigendum: Pharmacokinetic assessment of staphylococcal phage K following parenteral and intra-articular administration in rabbits (Front. Pharmacol., (2022), 13, 840165, 10.3389/fphar.2022.840165)

In the published article, there was an error. There was a typographical error included in the American Type Culture Collection (ATCC) reference number of phage K. A correction has been made to Materials and Methods, Bacteriophage. This sentence previously stated: “High-titer (2 × 10¹² pfu/ml ± 1 × 10¹ pfu/ml) purified phage K (ATCC 19695-B1) in phage buffer (100 mM NaCl, 10 mM MgCl Tris, pH 8.0) was prepared by TAILΦR Labs of Baylor College of Medicine (Houston, TX), as previously described (Green et al., 2017; Gibson et al., 2019; Terwilliger et al., 2021). Working stocks passed inhouse sterility and endotoxin testing (8 EU/mL endotoxin C). Stocks were lightprotected and stored at 4°C until administration. On study day 28, animals received 0.05 ml phage [10¹¹ ± 10¹ plaque forming units (pfu)] IA administered as above, or IV through an ear catheter with subsequent port flushing by saline or heparinized saline.” The corrected sentence appears below: “High-titer (2 × 10¹² pfu/mL ± 1 × 10¹ pfu/mL) purified phage K (ATCC 19685-B1) in phage buffer (100 mM NaCl, 10 mM MgCl Tris, pH 8.0) was prepared by TAILΦR Labs of Baylor College of Medicine (Houston, TX), as previously described (Green et al., 2017; Gibson et al., 2019; Terwilliger et al., 2021). Working stocks passed in-house sterility and endotoxin testing (8 EU/mL endotoxin C). Stocks were light-protected and stored at 4°C until administration. On study day 28, animals received 0.05 ml phage [10¹¹ ± 10¹ plaque forming units (pfu)] IA administered as above, or IV through an ear catheter with subsequent port flushing by saline or heparinized saline.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.